CompaniesByCap
XENE
Xenon Pharmaceuticals Inc. (XENE)
NASDAQ

Xenon Pharmaceuticals Inc. Income Statement 2012–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012
Revenues
Revenue7.5M009.4M18.4M32.2M6.8M311,0001.8M15.6M28.4M27.4M14.3M
Gross Profit
Profitability
Operating Income-373.1M-279.3M-214.1M-129.1M-79.0M-31.3M-42.8M-32.6M-24.8M-9.4M11.1M9.7M-3.2M
EBITDA
Net Income-345.9M-234.3M-182.4M-125.4M-78.9M-28.8M-41.6M-30.7M-23.0M-15.8M13.0M12.0M-4.3M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)79M78M67M61M44M35M28M18M15M14M4M2M1M

Xenon Pharmaceuticals Inc. Income Statement — FAQ

Xenon Pharmaceuticals Inc. (XENE) income statement over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see XENE's income statement history?

The chart and table above show Xenon Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.